Eton Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$31.2M
17 notices · 780,314 sh
Oct 2025 to Oct 2026
Reported ·
$8,679,434
8 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 8 reported sales carry the 10b5-1 box. Together they are 0.94% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-08-28MAIER PAUL V, Director$2,953,530
2026-08-24Krempa David, Chief Business Officer$1,626,750
2026-08-19BRYNJELSEN SEAN, President & CEO$6,343,000
2026-06-26Gruber James R., Chief Financial Officer$8,990,000
2026-06-25Gruber James R., Chief Financial Officer$875,251
2026-06-23Gruber James R., Chief Financial Officer$830,874
2026-06-17Adams Jennifer McKie, Director$1,618,500
Form 4, 2026-06-17: sold 50,000 at $32.48 Form 4 ↗
2026-06-02Gruber James R., Chief Financial Officer$84,163
2026-05-28BRYNJELSEN SEAN, President & CEO$3,888,000
Form 4, 2026-05-29: sold 120,000 at $31.88 Form 4 ↗
2026-05-22Krempa David, Chief Business Officer$3,500,000
Form 4, 2026-05-27: sold 100,000 at $32.30 Form 4 ↗
2026-01-14Krempa David, Chief Business Officer$30,334
2026-01-14Gruber James R., Chief Financial Officer$35,484
2026-01-14BRYNJELSEN SEAN, President & CEO$77,182
2025-12-12Gruber James R., Chief Financial Officer$91,996
2025-12-12BRYNJELSEN SEAN, President & CEO$135,631
2025-12-12Erdogan-Trinkaus Ipek, Chief Commercial Officer$1,674
2025-12-12Krempa David, Chief Business Officer$127,360